The Department of Health and Human Services will create a Foundry for American Biotechnology to produce technological solutions to address health security threats and enhance daily medical care, the agency announced today. The foundry will be located in Manchester, N.H., and managed in conjunction with the Advanced Regenerative Manufacturing Institute led by DEKA Research Corp., as part of a public-private partnership with HHS’ Office of the Assistant Secretary for Preparedness and Response. Its first project, a partnership with the Defense Advanced Research Projects Agency, will focus on maturing and validating small, automated devices that could go to disaster locations to make necessary medicines on site.

Headline
In this conversation, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk, break…
Headline
Boston Scientific announced Sept. 8 that the network disruption to its remote monitoring services following an Aug. 25 cyber incident has been resolved. The…
Headline
The Federal Office of Rural Health Policy’s Rural Health Redesign Center will host a webinar on Sept. 24 at 2 p.m. ET, where hospital CEOs will discuss the…
Headline
The FBI and the Department of Justice Aug. 26 announced the disruption of a China-linked hacking group known as QTFY. The group, which also identifies as QT…
Headline
Boston Scientific, a large supplier of medical devices, said in an Aug. 26 statement posted on its website that on Aug. 25 it “identified a cybersecurity…
Headline
The AHA’s Association for the Health Care Environment will host a webinar Sept. 8 at 2 p.m. ET that will discuss strategies environmental services leaders can…